Phase I/II pharmacokinetic study of oral hydroxyprogesterone caproate [LPCN 1107] in healthy women

Trial Profile

Phase I/II pharmacokinetic study of oral hydroxyprogesterone caproate [LPCN 1107] in healthy women

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 29 May 2014

At a glance

  • Drugs Hydroxyprogesterone (Primary)
  • Indications Preterm labour
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 May 2014 New trial record
    • 13 May 2014 This trial has completed enrolment, according to a Lipocine media release. Results are expected to be released in the second quarter of 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top